Scientific Publications

Home > Scientific Publications
Date Title
Jul 2022 Placenta-Derived Mesenchymal-like Adherent Stromal Cells as an Effective Cell Therapy for Cocaine Addiction in a Rat Model
May 2022 A functional corona around extracellular vesicles enhances angiogenesis, skin regeneration and immunomodulation
Feb 2022 Intramuscular and intratendinous placenta-derived mesenchymal stromal-like cell treatment of a chronic quadriceps tendon rupture
Jan 2021 Perinatal Cells: A Promising COVID-19 Therapy?
Sep 2020 Placenta-Derived Cell Therapy to Treat Patients With Respiratory Failure Due to Coronavirus Disease 2019
Jan 2020 Mesenchymal Stromal Cells from Fetal and Maternal Placenta Possess Key Similarities and Differences: Potential Implications for Their Applications in Regenerative Medicine
Aug 2019 Use of Human Placenta-Derived Cells in a Preclinical Model of Tendon Injury
Jan 2019 PLX-PAD Cell Treatment of Critical Limb Ischaemia: Rationale and Design of the PACE Trial
Nov 2018 Placenta-Derived Adherent Stromal Cell Therapy for Hematopoietic Disorders: A Case Study of PLX-R18
Oct 2018 Rescue from lethal acute radiation syndrome (ARS) with severe weight loss by secretome of intramuscularly injected human placental stromal cells
Oct 2018 Immunomodulatory placental-expanded, mesenchymal stromal cells improve muscle function
Feb 2018 Posttransplant Intramuscular Injection of PLX-R18 Mesenchymal-Like Adherent Stromal Cells Improves Human Hematopoietic Engraftment in A Murine Transplant Model
Jan 2018 Human Placental-Derived Adherent Stromal Cells Co-Induced with TNF-α and IFN-γ Inhibit Triple-Negative Breast Cancer in Nude Mouse Xenograft Models
Dec 2017 Placenta-derived PLX-PAD mesenchymal-like stromal cells are efficacious in rescuing blood flow in hind limb ischemia mouse model by a dose- and site-dependen
Oct 2017 Placenta-Derived Adherent Stromal Cells Improve Diabetes Mellitus-Associated Left Ventricular Diastolic Performance
Feb 2016 Human placenta-derived stromal cells decrease inflammation, placental injury and blood pressure in hypertensive pregnant mice
Oct 2015 In-vitro Optimization of Nanoparticle-Cell Labeling Protocols for In-vivo Cell Tracking Applications
Sep 2015 Mesenchymal Stromal Cells Prevent Allostimulation in vivo and Control CheckPoints of Th1 Priming: Migration of Human DC to Lymph Nodes and NK Cell Activation
Aug 2015 Concise Review: Process Development Considerations for Cell Therapy
Aug 2015 Critical elements in the development of cell therapy potency assays for ischemic conditions
Dec 2014 Human PLacental eXpanded (PLX) mesenchymal-like adherent stromal 2 cells confer neuroprotection to nerve growth factor (NGF)-differentiated 3 PC12 cells exposed to ischemia by secretion of IL-6 and VEGF
Mar 2014 Could Placental Cell Therapy be a Preemptive Approach to Protecting Women from Disabling Strokes?
Mar 2014 CELL THERAPIES – The Challenges & Possible Solutions for Transferring Cell Therapy From the Bench to the Industry
Nov 2013 Cardioprotection by placenta-derived stromal cells in a murine myocardial infarction model
Oct 2013 Self Healing- Article from European Biopharmaceutical Review
Oct 2013 Cell Therapy: Pushing Cells Around
Oct 2013 Commentary: A guide for potency assay development of cell-based product candidates
Jun 2013 Mitigation of Lethal Radiation Syndrome in Mice by Intramuscular Injection of 3D Cultured Adherent Human Placental Stromal Cells
Oct 2011 Meeting report of the first conference of the International Placenta Stem Cell Society (IPLASS)
Feb 2010 Transplantation of placenta-derived mesenchymal stromal cells upon experimental stroke in rats
Feb 2010 Toward cell therapy using placenta-derived cells: disease mechanisms, cell biology, preclinical studies, and regulatory aspects at the round table
Jun 2009 The role of placental-derived adherent stromal cell (PLX-PAD) in the treatment of critical limb ischemia
May 2009 Safety and Biodistribution Profile of Placental-derived Mesenchymal Stromal Cells (PLX-PAD) Following Intramuscular Delivery
Apr 2009 Cytokines as the Major Mechanism of MSC Clinical Activity: Expanding the Spectrum of Cell Therapy
Aug 2008 Placental-derived and expanded mesenchymal stromal cells (PLX-I) to enhance the engraftment of hematopoietic stem cells derived from umbilical cord blood